Sign in
CompletedNo phase

Role of Home-based Transcutaneous Electrical Acustimulation for Treatment of Pain in Patients With Chronic Pancreatitis

Key facts

Who runs it
University of Michigan
Where
Ann Arbor, United StatesSee the site
Trial code
Status
Completed
People taking part
12 people enrolled
Started
5 Oct 2023
Ended
1 Dec 2024
Type of study
Interventional
Treatments tested
  • Transcutaneous Electrical Acustimulation (TEA)
Record updated
4 February 2026

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Diagnosis of chronic pancreatitis (CP), based on a score greater or equal to 4 using a previously validated Mayo scoring system that uses morphologic and functional criteria, or endosonographic features suggestive or consistent with CP based on Rosemont criteria
  • Abdominal pain present at least once within the last month
  • Willing and able to provide written informed consent

Who cannot take part

  • Currently undergoing or about to start endoscopic therapy with Endoscopic retrograde cholangiopancreatography (ERCP) or Endoscopic ultrasound (EUS)
  • Recent history of acute pancreatitis as defined by the Revised Atlanta Classification within a month prior to enrollment
  • Self-reported daily use of opioids for > 12 months for weak opioids (codeine, tramadol and hydrocodone) or > 6 months for strong opioids (other opioids) in the last two years; -Self-reported ongoing illicit drug use or abuse-
  • Receiving chemotherapy for cancer
  • Scheduled for or with a history of pancreatic surgery (e.g. Total Pancreatectomy with Islet Auto Transplantation (TPIAT), Puestow, Frey, Whipple, other)
  • Radiologic and clinical findings consistent with symptomatic pseudocyst, wall-off necrosis, infected pancreatic necrosis, or biliary obstruction within the last 6 months
  • Suspected or diagnosed pancreatic cancer
  • Known allergy to adhesive electrocardiogram (ECG) electrodes
  • Pregnancy or breastfeeding mother
  • Imprisoned individuals
  • Non-English speaking patients
  • Patients with bilateral below the knee amputation
  • Patients with lower extremity paralysis
  • Patient is participating in another clinical trial
  • Patients with an implantable electrical stimulation device

Where in United States

  • University of MichiganAnn Arbor, United States

About the trial

What the trial wants to find out

This research is studying a new noninvasive device-based therapy called Transcutaneous Electrical Acustimulation (TEA) to learn about its safety and how well it works as a treatment of pain in chronic pancreatitis. The purpose of this study is to investigate the potential of TEA to treat abdominal pain in patients with chronic pancreatitis (CP).

Read full original descriptionShow less

The study hypothesizes that TEA can be used as a non-pharmaceutical opioid-free approach to treat pain in chronic pancreatitis.

The group in the trial

  • Transcutaneous Electrical Acustimulation (TEA)Treatment being tested

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Role of Home-based Transcutaneous Electrical Acustimulation for Treatment of Pain in Patients With Chronic Pancreatitis- A Pilot Study
Record updated
4 February 2026